Cargando…
Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?()
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859524/ https://www.ncbi.nlm.nih.gov/pubmed/31763435 http://dx.doi.org/10.1016/j.ijcha.2019.100404 |
| _version_ | 1783471135016353792 |
|---|---|
| author | Gupta, Kartik Prejean, Shane P. Vaduganathan, Muthiah Golwala, Harsh Watts, Thomas Evan Aryal, Sudeep R. von Mering, Gregory Booker, Oscar Julian Ahmed, Mustafa I. Bajaj, Navkaranbir S. |
| author_facet | Gupta, Kartik Prejean, Shane P. Vaduganathan, Muthiah Golwala, Harsh Watts, Thomas Evan Aryal, Sudeep R. von Mering, Gregory Booker, Oscar Julian Ahmed, Mustafa I. Bajaj, Navkaranbir S. |
| author_sort | Gupta, Kartik |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6859524 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68595242019-11-22 Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?() Gupta, Kartik Prejean, Shane P. Vaduganathan, Muthiah Golwala, Harsh Watts, Thomas Evan Aryal, Sudeep R. von Mering, Gregory Booker, Oscar Julian Ahmed, Mustafa I. Bajaj, Navkaranbir S. Int J Cardiol Heart Vasc Correspondence Elsevier 2019-07-17 /pmc/articles/PMC6859524/ /pubmed/31763435 http://dx.doi.org/10.1016/j.ijcha.2019.100404 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Correspondence Gupta, Kartik Prejean, Shane P. Vaduganathan, Muthiah Golwala, Harsh Watts, Thomas Evan Aryal, Sudeep R. von Mering, Gregory Booker, Oscar Julian Ahmed, Mustafa I. Bajaj, Navkaranbir S. Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?() |
| title | Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?() |
| title_full | Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?() |
| title_fullStr | Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?() |
| title_full_unstemmed | Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?() |
| title_short | Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?() |
| title_sort | does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?() |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859524/ https://www.ncbi.nlm.nih.gov/pubmed/31763435 http://dx.doi.org/10.1016/j.ijcha.2019.100404 |
| work_keys_str_mv | AT guptakartik doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT prejeanshanep doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT vaduganathanmuthiah doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT golwalaharsh doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT wattsthomasevan doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT aryalsudeepr doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT vonmeringgregory doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT bookeroscarjulian doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT ahmedmustafai doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents AT bajajnavkaranbirs doesdualvstripleantithrombotictherapyafterpercutaneouscoronaryinterventioninpatientswithatrialfibrillationlowertheriskofbleedingatthecostofincreasedriskofischemicevents |